The Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded Ology Bioservices Inc. with three biomanufacturing contracts with a combined value of more than $16 million.   In the first program, valued at $8.5 million, Ology Bioservices will manufacture a conjugated vaccine candidate comprising the conserved protein from the bacterium Burkholderia pseudomallei and the adjuvant CPS-CRM-197. The vaccine candidate, develo...